ACTRN12614000248662尚未招募2 期
Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- SW
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Cannabis dependency
排除标准
- •Poly substance dependence, Co-morbid Mental Health Diagnosis, Intellectual disability, Substance abuse treatment in previous 30 days, Evidence of severe medical condition (cardiac, renal, hepatic), Pregnant women or those wishing to start a family imminently, not willing to abide by NSW Health rules for inpatient admission.
研究者
相似试验
招募中
2 期
Cannabiol (CBD) for Cannabis and Mood Disorders in Young Adults (CCAMDYA)ACTRN12616001001482St Vincent's Hospital Melbourne30
进行中（未招募）
2 期
Cannabidiol for the treatment of patients at a high-risk of psychosisISRCTN10334895King’s College London and South London and Maudsley NHS Foundation Trust300
招募中
3 期
Cannabidiol for treatment of non-affective psychosis and cannabis use2024-517630-18-00Region Hovedstaden64
进行中（未招募）
1 期
Cannabidiol as an add-on therapy in treatment-refractory psychotic disordersMedDRA version: 16.1Level: HLGTClassification code 10039628Term: Schizophrenia and other psychotic disordersSystem Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2013-000240-26-GBKing's College London
招募中
1 期
Cannabidiol as an Adjunct for the Treatment of Anorexia Nervosa (CAFTAN): An Open Label Pilot Trial with Extension in Young PeopleMental Health - Eating disordersAnorexia nervosaACTRN12622001306707niversity of Sydney30